6. .
WHEN YOU ARE USING TCI
ā¤ Faster achievement of a therapeutic concentration and a
reliable maintenance
ā¤ Optimum doses of the drug
ā¤ Reduces work
ā¤ Lesser chance for errors
ā¤ You can use the pump for induction too
ā¤ TIVA using Propofol TCI + Remifentanil TCI will provide a near
perfect choice for neuroanesthesia: easily titratable hypnosis &
analgesia, fast recovery
7. .
MANUALLY CONTROLLED INFUSION
(MCI)
ā¤ Without an appropriate bolus, a constant propofol infusion at
10 mg/kg/h requires 40ā90 min to achieve a clinically useful
plasma concentration of 4 Ī¼g/ml in an 85 kg adult male
Bolus
8. .
TCI INDUCTION & MAINTENANCE
ā¤ Propofol: start with a target concentration 3-4 ug/ml; titrate up
by 0.5ā1 Ī¼g/ml to reach LOC; note the concentration at which
there is no response to a noxious stimulus
ā¤ Target concentration (5-8 ng/ml) of remifentanil; adjust during
placement of the Mayfield head holder [manual 0.08ā0.25
ug/kg/min]
ā¤ Remifentanil has little hypnotic action
9. .
FRESH PAIR
ā¤ Good synergism
ā¤ Maintenance: Propofol target concentrations of 3.0ā6.0
ug/ml(without opioids) or 2.5ā4.0 ug/ml (with opioids)
ā¤ Target remifentanil concentrations up to 10ā15 ng/ml may
be required during procedures involving cranial nerve
stimulation or extensive craniotomies,
ā¤ May be associated with acute tolerance or hyperalgesia.
ā¤ The remifentanil infusion can be continued at a target of
1ā2 ng mlā1 to smooth extubation if desired. Better cough
suppression
10. .
TCI EFFECT SITE CONCENTRATIONS
ā¤ Ferreira et al predicted the Propofol Ce at various stages of
neurosurgical anesthesia.
ā¤ Prop Ce at intubation: 5 Ā±1 , incision: 2.6 Ā± 0.9 , and
extubation: 1 Ā± 0.3 Ī¼g/mL.
ā¤ Remifentanil Ce at intubation: 2.2 Ā± 0.3 , incision: 6 Ā± 2.6, and
extubation: 2.2 Ā± 0.9 Ī¼g/mL.
11. .
SOMETIMES COMPOSURE IS BETTER
THAN AGGRESSION
ā¤ During induction --> TCI uses smaller doses, and slower
infusion rates, --> attenuate the reduction of MAP --> impaired
cerebral autoregulation --> safer way of induction in aneurysm
surgeries and TBI
12. .
IONM
ā¤ Anesthesia influences IONM and provision of a comparable
anesthesia throughout the surgery increases the reliability of
the signals and reduces confounding in interpreting the cause
of a derangement (pharmacological vs neurosurgical)
ā¤ Avoids a disastrous light plane of anesthesia or a too deep
plane causing hypotension which can affect the monitoring
13. .
WHILE EEG IS BEING MONITORED
ā¤ TCI allows a constant level of anesthetic effect --> avoid
misinterpretation of EEG depression caused by boluses or
rapid changes in anesthetic level from true insults
14. .
TCI FOR AWAKE CRANIOTOMY
ā¤ TCI Propofol + TCI Remifentanil moderate sedation
ā¤ TCI Propofol + TCI Remifentanil Asleep-Awake-Asleep (GA)
ā¤ Optimal use of the short acting agents using TCIā¦an excellent
choice
ā¤ Remifentanil: spontaneous ventilation is uncommon with
concentrations > 1.5 ng/ml
15. .
DONāT OVER ESTIMATE!
ā¤ Propofol: Schneider superior to Marsh. For intraoperative
neurological testing -->propofol concentrations as low as 0.8
ug/mL.
ā¤ Marsh (Cplasma=1.3 Ā± 0.5 ug/mL)
ā¤ Schnider model (Cplasma=1.0 Ā± 0.4 ug/mL).
16. .
TIME CHANGES EVERYONE; SPEND MORE
TIME WITH THEM!
ā¤ The Schnider TCI Vs Manual Propofol
ā¤ A slower induction of anaesthesia may be achieved by setting
a lower initial target propofol (e.g. 1 ug/ml) and making
repeated 0.5ā1 ug/ml incremental increases in the target
concentration.
18. .
VERY LIMITED OPTIONS
ā¤ Marsh, Schnider : Propofol
ā¤ Minto: Remifentanil*
ā¤ The Kataria model
ā¤ The Paedfusor model
19. .
TCI ALSO FINDS IT DIFFICULT TO
TACKLE OBESITY
ā¤ Current TCI models are not formally validated for use in such
patients
ā¤ Marsh : upto 150 kg
ā¤ Schnider model : BMI < 35 kg.m-2 for women or < 42 kg.m-2 for
men.
ā¤ pEEG monitoring
ā¤ Minto: above the critical value, inadequate bolus dose and
infusion rate
20. .
ACCURATE DOSING
ā¤ The ācorrectā body mass to use with TIVA has been investigated and
currently Servin's formula for calculating an input mass for TCI
infusions seems most useful:
ā¤ where ideal body weight= ideal BMI (male 22, female 26) Ć height2(m)
Input mass =(ideal body weight)+ 0.4Ć(actualāideal)
21. .
PEDIATRIC POPULATION
ā¤ The Kataria model : patients aged 3ā16 yr with weight of 15-61
kg.
ā¤ The Paedfusor model : for patients 1ā16 yr of age and
weighing 5ā61 kg
ā¤ Remifentanil adult TCI targets using the Minto model for
patients aged ā„ 12 years and weighing ā„ 30 kg.
ā¤ MRI sedation: you cant use DOA monitoring
Havenāt
heard
about
these!?
22. .
PEDIATRIC POPULATION
ā¤ When switching to TIVA following a gaseous induction:
ā¤ Set an initial propofol target of 4 ug/ml and decreasing the
target after the pump indicates that a 2ā3 mg/kg bolus has
been delivered
ā¤ With remifentanil, propofol target can be reduced by up to 50%
(2.5ā 4 ug/ml) in children aged < 12 years; else propofol will
accumulate.
23. .
OTHER PROBLEMS
ā¤ Renal dysfunction, CCF, liver dysfunction
ā¤ Neurosurgical patients taking AEDs and other enzyme
inducers: Actual concentration difficult to predict
ā¤ Synergism: Well known between Propofol and Remifentanil
when used in the TCI-TIVA mode. Both drugs reaching target
plasma/effect site concentration at the same time is important
ā¤ Unknown interaction between all other agents without a PK
model for TCI
ā¤ Ignorance about the models: e.g. Schneider in plasma
targeting may underdoseā¦may reflect during pinning
ā¤ In Marsh model age is an input only to ensure that the patient
is ā„16 yr. It should better be used in plasma targeting mode
only.
25. .
IF USING MCI, AND IF YOU BELIEVE IN
PHARMACOKINETICS
MCI propofol infusion regimen, designed to give a plasma concentration of 3 Ī¼g/ml: 1
mg/kg bolus f/b 10mg/kg/h, reduced to 8mg/kg/h at 10min, reduced to 6mg/kg/h at 20
min
Tea
time
26. .
MCI LAGSā¦..
ā¤ A fixed infusion rate --> rising, declining or stable concentrations
-->under or overdosage.
ā¤ For increasing the depth --> a bolus f/b a higher infusion rate
and for reducing the depth, a pause f/b a lower infusion rate -->
still the plasma conc lags--> more lag for Ce --> more lag for
clinical effect
27. .
BUT, YOU CANT LIVE WITHOUT MCI!
ā¤ Popular TCI models only for propofol and opioids
ā¤ In India, along with the propofol TCI, fentanyl has to be
administered as manual infusion
ā¤ Ketamine is a reemerging drug in neuroanesthesia
ā¤ Remifentanil: For children <12y : use a manual infusion, 0.2ā0.5
ug/kg/min
28. .
YES WE NEED MCI!
ā¤ In diseases with end organ dysfunction
ā¤ Also in neurosurgical patients on AEDs
ā¤ propofol+fentanyl+dexmedetomidine with IONM?
ā¤ Single syringe TIVA?
29. DEXMEDETOMIDINE: IS IT THE MOST
SUITABLE DRUG (MSD) IN
AWAKE CRANIOTOMIES ??!!
ā¤ Calm, cool patient!
ā¤ Anxiolysis-Analgesic-Opioid sparing*
ā¤ No effect on ICP
ā¤ Less respiratory depressionļ less hypercapnia
ā¤ Easily arousable despite sedation ; less PONV
30. .
TIVA WITH MANUALLY CONTROLLED
INFUSIONS: PLEASE NOTE
ā¢ The anesthesiologist has to spend time for dose calculation and its
titration throughout the procedure
ā¢ Importance of depth of anesthesia monitoring increases
ā¢ May affect the predictability of the recovery
ā¢ Over or under consumption of the drug/s
IF TCI NEEDS THIS
VIGILANCE
MCI NEEDS, THIS
VIGILANCE
31. āTEACHING TIVA MEANS TEACHING
A LOT OF ANESTHESIOLOGY
ITāS A GREAT
TRAINING TOOL
ā¦ā¦ā¦ā¦ā¦ā¦ā¦ā¦ā¦ā¦ā¦ā¦ā¦ā¦ā¦ā¦ā¦ā¦ā¦ā¦ā¦ā¦ā¦..
32. THANK YOUVisit me @ The Lay Medical Man blog
www.thelaymedicalman.wordpress.co